Differential survival for men and women with HIV/AIDS-related neurologic diagnoses

PLoS ONE

Volumn 10, Issue 6, 2015, Pages

  Carvour, Martha L ^a,b   Harms, Jerald P ^c   Lynch, Charles F ^a   Mayer, Randall R ^c   Meier, Jeffery L ^b,d   Liu, Dawei ^b   Torner, James C ^a  

^a UNIVERSITY OF IOWA   (United States)

^b UNIVERSITY OF IOWA   (United States)

^c Medical Scientist Training Program University of Iowa ^*  (United States)

^d VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; COHORT ANALYSIS; CRYPTOCOCCAL MENINGITIS; DISEASE COURSE; FEMALE; HIV ASSOCIATED DEMENTIA; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; MALE; MENINGOENCEPHALITIS; NEUROLOGIC DISEASE; OUTCOME ASSESSMENT; PRIMARY CENTRAL NERVOUS SYSTEM LYMPHOMA; PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY; RETROSPECTIVE STUDY; SEX DIFFERENCE; SURVIVAL RATE; SURVIVAL TIME; COMPLICATION; DEPRESSION; HIV INFECTIONS; HUMAN IMMUNODEFICIENCY VIRUS; KAPLAN MEIER METHOD; MIDDLE AGED; NERVOUS SYSTEM DISEASES; PATHOGENICITY; PATHOLOGY; RISK FACTOR; SEXUAL DEVELOPMENT; VIROLOGY;

HUMAN IMMUNODEFICIENCY VIRUS;

ADULT; DEPRESSION; FEMALE; HIV; HIV INFECTIONS; HUMANS; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; NERVOUS SYSTEM DISEASES; RISK FACTORS; SEX CHARACTERISTICS;

EID: 84939140002     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0123119     Document Type: Article

References (27)

1. Dal Pan GJ, McArthur JC. Neuroepidemiology of HIV infection. Neurologic Clinics. 1996; 14: 359-382. PMID: 8827177
2. Vivithanaporn P, Heo G, Gamble J, Krentz HB, Hoke A, Gill MJ, et al. Neurologic disease burden in treated HIV/AIDS predicts survival: a population-based study. Neurology. 2010; 75: 1150-1158. doi: 10.1212/WNL.0b013e3181f4d5bb PMID: 20739646
3. Mocroft A, Sterne JA, Egger M, May M, Grabar S, Furrer H, et al. Variable impact on mortality of AIDS-defining events diagnosed during combination antiretroviral therapy: not all AIDS-defining conditions are created equal. Clin Infect Dis. 2009; 48: 1138-1151. doi: 10.1086/597468 PMID: 19275498
4. United States Department of Agriculture. USDA ERS - Urban Influence Codes. Available: http://www.ers.usda.gov/data-products/urban-influence-codes.aspx. Accessed 2015 March 25.
5. Smith T, Smith B, Ryan M. Survival Analysis Using Cox Proportional Hazards Modeling for Single and Multiple Event Time Data. Available: http://www2.sas.com/proceedings/sugi28/254-28.pdf, page 5. Accessed 2014 September 25.
6. Bilgrami M, O'Keefe P. Neurologic diseases in HIV-infected patients. Handbook of Clinical Neurology. 2014; 121: 1321-1344. doi: 10.1016/B978-0-7020-4088-7.00090-0 PMID: 24365422
7. Price RW, Spudich SS, Peterson J, Joseph S, Fuchs D, Zetterberg H, et al. Evolving character of chronic central nervous system HIV infection. Seminars in Neurology. 2014; 34: 7-13. doi: 10.1055/s-0034-1372337 PMID: 24715483
8. Centers for Disease Control and Prevention. CDC HIV Surveillance - Women. Available: http://www.cdc.gov/hiv/pdf/statistics-surveillance-Women.pdf. Accessed 2014 September 17.
9. Ellerbrock TV, Bush TJ, Chamberland ME, Oxtoby MJ. Epidemiology of women with AIDS in the United States, 1981 through 1990. A comparison with heterosexual men with AIDS. JAMA. 1991; 265: 2971-2975. PMID: 2033768
10. Iatrakis GM, Shah PN, Smith JR, Kitchen VS, Barton SE. Survival of men and women with AIDS: a comparative study. Genitourinary Medicine. 1994; 70: 290. PMID: 7959718
11. Vella S, Giuliano M, Floridia M, Chiesi A, Tomino C, Seeber A, et al. Effect of sex, age and transmission category on the progression to AIDS and survival of zidovudine-treated symptomatic patients. AIDS. 1995; 9: 51-56. PMID: 7893441
12. Phillips AN, Antunes F, Stergious G, Ranki A, Jensen GF, Bentwich Z, et al. A sex comparison of rates of new AIDS-defining disease and death in 2554 AIDS cases. AIDS in Europe Study Group. AIDS. 1994; 8: 831-835. PMID: 8086143
13. Cozzi Lepri A, Pezzotti P, Dorrucci M, Phillips AN, Rezza G. HIV disease progression in 854 women and men infected through injecting drug use and heterosexual sex and followed for up to nine years from seroconversion. Italian Seroconversion Study. BMJ. 1994; 309: 1537-1542. PMID: 7819892
14. von Overbeck J, Egger M, Smith GD, Schoep M, Ledergerber B, Furrer H, et al. Survival in HIV infection: do sex and category of transmission matter? Swiss HIV Cohort Study. AIDS. 1994; 8: 1307-1313. PMID: 7802985
15. Fanjul F, Riveiro-Barciela M, Gonzalez J, Delgado E, Murillas J, Payeras Cifre A, et al. Evaluation of progressive multifocal leukoencephalopathy treatments in a Spanish cohort of HIV-infected patients: do protease inhibitors improve survival regardless of central nervous system penetration-effectiveness (CPE) score? HIV Medicine. 2013; 14: 321-325. doi: 10.1111/hiv.12008 PMID: 23217049
16. Melnick SL, Sherer R, Louis TA, Hillman D, Rodriguez EM, Lackman C, et al. Survival and disease progression according to gender of patients with HIV infection. The Terry Beirn Community Programs for Clinical Research on AIDS. JAMA. 1994; 272: 1915-1921. PMID: 7990243
17. Lemp GF, Hirozawa AM, Cohen JB, Derish PA, McKinney KC, Hernandez SR. Survival for women and men with AIDS. The Journal of Infectious Diseases. 1992; 166: 74-79. PMID: 1607710
18. Prins M, Robertson JR, Brettle RP, Aguado IH, Broers B, Boufassa F, et al. Do gender differences in CD4 cell counts matter? AIDS. 1999; 13: 2361-2364. PMID: 10597777
19. Garcia de la Hera M, Ferreros I, del Amo J, Garcia de Olalla P, Perez Hoyos S, Muga R, et al. Gender differences in progression to AIDS and death from HIV seroconversion in a cohort of injecting drug users from 1986 to 2001. Journal of Epidemiology and Community Health. 2004; 58: 944-950. PMID: 15483312
20. Jarrin I, Geskus R, Bhaskaran K, Prins M, Perez-Hoyos S, Muga R, et al. Gender differences in HIV progression to AIDS and death in industrialized countries: slower disease progression following HIV seroconversion in women. American Journal of Epidemiology. 2008; 168: 532-540. doi: 10.1093/aje/kwn179 PMID: 18663213
21. Poundstone KE, Chaisson RE, Moore RD. Differences in HIV disease progression by injection drug use and by sex in the era of highly active antiretroviral therapy. AIDS. 2001; 15: 1115-1123. PMID: 11416713
22. Prins M, Meyer L, Hessol NA. Sex and the course of HIV infection in the pre- and highly active antiretroviral therapy eras. AIDS. 2005; 19: 357-370. PMID: 15750389
23. Kempf MC, Pisu M, Dumcheva A, Westfall AO, Kilby JM, Saag MS. Gender differences in discontinuation of antiretroviral treatment regimens. Journal of Acquired Immune Deficiency Syndromes. 2009; 52: 336-341. doi: 10.1097/QAI.0b013e3181b628be PMID: 19654551
24. Robertson KR, Kapoor C, Robertson WT, Fiscus S, Ford S, Hall CD. No gender differences in the progression of nervous system disease in HIV infection. Journal of Acquired Immune Deficiency Syndromes. 2004; 36: 817-822. PMID: 15213565
25. Wilson ME, Dimayuga FO, Reed JL, Curry TE, Anderson CF, Nath A, et al. Immune modulation by estrogens: role in CNS HIV-1 infection. Endocrine. 2006; 29: 289-297. PMID: 16785604
26. Hessol NA, Kalinowski A, Benning L, Mullen J, Young M, Palella F, et al. Mortality among participants in the Multicenter AIDS Cohort Study and the Women's Interagency HIV Study. Clin Infect Dis. 2007; 44: 287-294. PMID: 17173233
27. Gutierrez F, Garcia L, Padilla S, Alvarez D, Moreno S, Navarro G, et al. Risk of clinically significant depression in HIV-infected patients: effect of antiretroviral drugs. HIV Medicine. 2014; 15: 213-223. doi: 10.1111/hiv.12104 PMID: 24215356